110 related articles for article (PubMed ID: 25611265)
1. Investigation of inflammatory activity in ulcerative colitis.
Boldeanu MV; Siloşi I; Ghiluşi M; Cojocaru M; Biciuşcă V; Avrămescu CS; Cojocaru IM; Ciurea T; Albu DF; Siloşi CA
Rom J Morphol Embryol; 2014; 55(4):1345-51. PubMed ID: 25611265
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
Niederau C; Backmerhoff F; Schumacher B; Niederau C
Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
[TBL] [Abstract][Full Text] [Related]
4. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis.
Mawdsley JE; Macey MG; Feakins RM; Langmead L; Rampton DS
Gastroenterology; 2006 Aug; 131(2):410-9. PubMed ID: 16890594
[TBL] [Abstract][Full Text] [Related]
5. Interleukins IL-33 and IL-17/IL-17A in patients with ulcerative colitis.
Ajduković J; Tonkić A; Salamunić I; Hozo I; Simunić M; Bonacin D
Hepatogastroenterology; 2010; 57(104):1442-4. PubMed ID: 21443100
[TBL] [Abstract][Full Text] [Related]
6. Expression and clinical significance of IL-17 and IL-17 receptor in ulcerative colitis.
Zhang H; Xia B; Li J; Zhao Q; Chen ZT; Zhou R; Wu J
J Huazhong Univ Sci Technolog Med Sci; 2016 Feb; 36(1):37-40. PubMed ID: 26838737
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases (MMP-3 and MMP-9) implication in the pathogenesis of inflammatory bowel disease (IBD).
Siloşi I; Boldeanu MV; Mogoantă SŞ; Ghiluşi M; Cojocaru M; Biciuşcă V; Cojocaru IM; Avrămescu CS; Gheonea DI; Siloşi CA; Turculeanu A
Rom J Morphol Embryol; 2014; 55(4):1317-24. PubMed ID: 25611261
[TBL] [Abstract][Full Text] [Related]
8. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
[TBL] [Abstract][Full Text] [Related]
9. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
Ciećko-Michalska I; Fedak D; Mach T
Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
[TBL] [Abstract][Full Text] [Related]
10. Serum IL-17A in newly diagnosed treatment-naive patients with ulcerative colitis reflects clinical disease severity and predicts the course of disease.
Ohman L; Dahlén R; Isaksson S; Sjöling A; Wick MJ; Sjövall H; Van Oudenhove L; Simrén M; Strid H
Inflamm Bowel Dis; 2013 Oct; 19(11):2433-9. PubMed ID: 23966065
[TBL] [Abstract][Full Text] [Related]
11. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis.
Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J
Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866
[TBL] [Abstract][Full Text] [Related]
12. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-17 serum levels and TLR4 polymorphisms in ulcerative colitis.
Mohammadi M; Zahedi MJ; Nikpoor AR; Baneshi MR; Hayatbakhsh MM
Iran J Immunol; 2013 Jun; 10(2):83-92. PubMed ID: 23811547
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.
Heller F; Florian P; Bojarski C; Richter J; Christ M; Hillenbrand B; Mankertz J; Gitter AH; Bürgel N; Fromm M; Zeitz M; Fuss I; Strober W; Schulzke JD
Gastroenterology; 2005 Aug; 129(2):550-64. PubMed ID: 16083712
[TBL] [Abstract][Full Text] [Related]
15. Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease.
Ludwiczek O; Vannier E; Borggraefe I; Kaser A; Siegmund B; Dinarello CA; Tilg H
Clin Exp Immunol; 2004 Nov; 138(2):323-9. PubMed ID: 15498044
[TBL] [Abstract][Full Text] [Related]
16. Expression of inflammatory genes in the colon of ulcerative colitis patients varies with activity both at the mRNA and protein level.
Verma R; Verma N; Paul J
Eur Cytokine Netw; 2013; 24(3):130-8. PubMed ID: 24197332
[TBL] [Abstract][Full Text] [Related]
17. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
[TBL] [Abstract][Full Text] [Related]
18. Systemic metabolic signaling in acute and chronic gastrointestinal inflammation of inflammatory bowel diseases.
Karrasch T; Obermeier F; Straub RH
Horm Metab Res; 2014 Jun; 46(6):445-51. PubMed ID: 24799023
[TBL] [Abstract][Full Text] [Related]
19. Expression and release of leptin and proinflammatory cytokines in patients with ulcerative colitis and infectious diarrhea.
Biesiada G; Czepiel J; Ptak-Belowska A; Targosz A; Krzysiek-Maczka G; Strzalka M; Konturek SJ; Brzozowski T; Mach T
J Physiol Pharmacol; 2012 Oct; 63(5):471-81. PubMed ID: 23211301
[TBL] [Abstract][Full Text] [Related]
20. The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis.
Murata Y; Ishiguro Y; Itoh J; Munakata A; Yoshida Y
J Gastroenterol; 1995 Nov; 30 Suppl 8():56-60. PubMed ID: 8563892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
